INTRODUCTION: The present study aimed at comparing the efficacy in recognizing depression, in 53 patients newly diagnosed with lung cancer, of the Hospital Anxiety and Depression Scale (HADS), a self-report screening questionnaire, and the Montgomery-Asberg Depression Rating Scale (MADRS), a semi-structured clinician-rated interview. Specifically, we aimed at addressing the question of which is the best HADS cutoff for the detection of patients to be further investigated through a clinical semi-structured interview (the MADRS). RESULTS: The MADRS identified 92% of the patients as depressed; the HADS, 70% and 87%, using a cutoff of 11 and 8, respectively. The results suggest substantial agreement between the HADS and the MADRS when a cutoff of 8 is used (McNemar: p = 0.51; Cohen K = 0.69), while a HADS cutoff of 11 resulted in a significantly lower concordance with the MADRS (McNemar: p = 0.002; Cohen K = 0.49).
INTRODUCTION: The present study aimed at comparing the efficacy in recognizing depression, in 53 patients newly diagnosed with lung cancer, of the Hospital Anxiety and Depression Scale (HADS), a self-report screening questionnaire, and the Montgomery-Asberg Depression Rating Scale (MADRS), a semi-structured clinician-rated interview. Specifically, we aimed at addressing the question of which is the best HADS cutoff for the detection of patients to be further investigated through a clinical semi-structured interview (the MADRS). RESULTS: The MADRS identified 92% of the patients as depressed; the HADS, 70% and 87%, using a cutoff of 11 and 8, respectively. The results suggest substantial agreement between the HADS and the MADRS when a cutoff of 8 is used (McNemar: p = 0.51; Cohen K = 0.69), while a HADS cutoff of 11 resulted in a significantly lower concordance with the MADRS (McNemar: p = 0.002; Cohen K = 0.49).
Authors: Cristina Civilotti; Daniela Acquadro Maran; Francesca Santagata; Antonella Varetto; Maria Rosa Stanizzo Journal: Support Care Cancer Date: 2020-02-08 Impact factor: 3.603
Authors: Robert Hung; Paul Krebs; Elliot J Coups; Marc B Feinstein; Bernard J Park; Jack Burkhalter; Jamie S Ostroff Journal: J Pain Symptom Manage Date: 2011-01-08 Impact factor: 3.612
Authors: Talia R Weiss Wiesel; Christian J Nelson; William P Tew; Molly Hardt; Supriya Gupta Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Ajeet Gajra; Stuart M Lichtman; Rupal Ramani; Vani Katheria; Laura Zavala; Arti Hurria Journal: Psychooncology Date: 2014-08-06 Impact factor: 3.894
Authors: Melanie P J Schellekens; Desiree G M van den Hurk; Judith B Prins; Johan Molema; A Rogier T Donders; Willem H Woertman; Miep A van der Drift; Anne E M Speckens Journal: BMC Cancer Date: 2014-01-03 Impact factor: 4.430